- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hematologic Disease in United States
Total 147311 results
-
Gamida Cell ltdActive, not recruitingHematological MalignanciesUnited States
-
Esanex Inc.Completed
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
National Human Genome Research Institute (NHGRI)RecruitingRare Diseases | Inherited Hematological Diseases | FPDMMUnited States
-
University of Michigan Rogel Cancer CenterOtsuka Pharmaceutical Development & Commercialization, Inc.Completed
-
M.D. Anderson Cancer CenterImmunoGen, Inc.Completed
-
Acrotech Biopharma Inc.Axis Clinicals LimitedTerminatedRelapsed/Refractory Solid Tumors/Hematological MalignanciesUnited States
-
Emory UniversityTerminatedThrombocytopenia | Hematological MalignanciesUnited States
-
Kangpu Biopharmaceuticals, Ltd.RecruitingHematological MalignanciesUnited States
-
St. Jude Children's Research HospitalCompleted
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
M.D. Anderson Cancer CenterICN PharmaceuticalsCompletedHematological MalignanciesUnited States
-
Anthony Sung, MDMassachusetts General HospitalCompleted
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
Vlad RadulescuCompletedCancer | Infertility | Rheumatologic Disorder | Hematologic DisorderUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCancer and Aging Research GroupRecruitingLymphoma | Leukemia | MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteCompletedHematological MalignanciesUnited States
-
ExCellThera inc.Fred Hutchinson Cancer CenterActive, not recruitingHigh Risk Hematological Malignancy | Cord Blood TransplantUnited States, Netherlands
-
Gilead SciencesTerminatedHematological MalignanciesUnited States, United Kingdom
-
IncuronTerminatedHematological MalignanciesUnited States
-
Gemin XCompletedHematological MalignanciesUnited States, Canada
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, Japan, Taiwan, Australia, Germany, China
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingSG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.Lymphoma | Hematological MalignancyUnited States
-
Effector TherapeuticsTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Myeloma | Hematological MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Leukemia | Myelodysplastic SyndromeUnited States
-
St. Jude Children's Research HospitalCompletedHematological DiseasesUnited States
-
HutchmedRecruitingIsocitrate Dehydrogenase Gene MutationSpain, United States
-
Medical College of WisconsinRecruitingMultiple Myeloma | Hematological MalignancyUnited States
-
St. Jude Children's Research HospitalNot yet recruitingLymphoma | Hematologic Malignancy | MDS | AML, Childhood | ALL, ChildhoodUnited States
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminatedLymphoma | Leukemia | Myelodysplastic Syndrome | Hematological MalignanciesUnited States
-
Matthew DallosBristol-Myers SquibbTerminatedSolid Tumor | Sars-CoV2 | Hematological MalignancyUnited States
-
Karyopharm Therapeutics IncCompletedHematological MalignanciesUnited States, Denmark, Canada
-
Synta Pharmaceuticals Corp.CompletedLymphoma | Leukemia | Hematological Malignancies | Metastatic or Unresectable Solid TumorsUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingHematological MalignanciesUnited States, Canada, Brazil, Chile, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
Medical College of WisconsinTerminatedLymphoma | Myelodysplastic Syndromes | Acute Leukemia | Chronic LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndromes | LeukemiaUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedAML | MDS | Leukemia, Lymphocytic, AcuteUnited States
-
St. Jude Children's Research HospitalRecruitingRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
University of Colorado, DenverNot yet recruitingHematologic Malignancy | Pediatric Patients | Other Hematologic ConditionUnited States
-
Alla KeyznerCompletedMyelodysplastic Syndromes | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Acute Leukemia in Remission | Hematological Malignancy | Acute Lymphoblastic Leukemia in RemissionUnited States
-
Brigham and Women's HospitalDana-Farber Cancer Institute; Robert Wood Johnson Foundation; American Society...RecruitingHematologic MalignancyUnited States
-
Prolacta BioscienceRecruiting
-
Dana-Farber Cancer InstituteRecruiting
-
Northside Hospital, Inc.RecruitingHematologic MalignancyUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematologic MalignancyUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Withdrawn
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI)RecruitingHematologic Malignancy | Hematologic CancerUnited States